During the past decade, Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital" #1 sponsor was "NSABP Foundation Inc" with 2 trials, followed by "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored, "Radiation Therapy Oncology Group" with 1 trials sponsored and "SWOG Cancer Research Network" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "American College of Surgeons" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital" are "Breast Cancer" (4 trials), "Metastatic Cancer" (1 trials), "Pancreatic Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital" in a lesser frequency.

Most popular intervention types in "Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital" are "Drug" (5 trials), "Radiation" (3 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "tamoxifen citrate" (2 trials), "3-dimensional conformal accelerated partial breast irradiation" (1 trials), "Calcium supplement" (1 trials), "GnRH agonist" (1 trials) and "MammoSite or other single-entry intracavitary device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital" are 4 trials for "Female" genders, 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".